NYOH study shows cancer drug could help coronavirus patients with breathing problems

WNYT Staff
Updated: June 05, 2020 07:51 PM
Created: June 05, 2020 05:03 PM

A new case study involving New York Oncology Hematology, may have found a treatment for the severe breathing problems many coronavirus patients experience.

Ventilators are used when the oxygen level in these patients falls dangerously low.


The oxygen drop happens because of a cytokine storm, which is when the body goes into overdrive to fight the virus but ends up causing inflammation and potentially deadly damage.

A researcher at U.S. Oncology, parent company of NYOH, theorized a cancer drug, acalabrutinib, could tamp down that immune response, and it did.

Copyright 2020 - WNYT-TV, LLC A Hubbard Broadcasting Company

Comment on Facebook
Judge denies motion to dismiss lawsuit against St. Clare's Corporation

Biden, Gates, other Twitter accounts hacked in Bitcoin scam

Saratoga businesses adapt to welcome fans who can't go to track

Nursing homes can resume visitors Wednesday

RPI researchers looking into common drug as possible coronavirus treatment